Mapel DW, Robinson SB, Dastani HB, Shah H, Phillips AL, Lydick E. The Direct Medical Costs of Undiagnosed Chronic Obstructive Pulmonary Disease. Value in Health 11(4):628-636, 2008; Epub 2008 Jan 8
|
Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, Dalal A, Scharf SM. Burden of concomitant asthma and COPD in a Medicaid population. Chest 134(1): 14-19, 2008
|
Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, Wouters E, Sethi S, Cooper CB. COPD as a Lung Disease with Systemic Consequences—Clinical Impact, Mechanisms, and Potential for Early Intervention. COPD 5(4):235-256, 2008.
|
Goff SL, Feld A, Andrade SE, Mahoney L, Beaton SJ, Boudreau DM, Davis RL, Goodman M, Hartsfield CL, Platt R,Roblin D, Smith D, Yood MU, Dodd K, Gurwitz JH. Administrative Data Used to Identify Patients with Irritable Bowel Syndrome. Journal of Clinical Epidemiology 61(6):617-621, 2008. Epub 2008 Mar 4.
|
Parshall MB, Mapel DW, Rice L, Williams A, O’Reilly J. Predictive Validity of Short-Form Health Survey [36 items] Scales for Chronic Obstructive Pulmonary Disease Exacerbation. Heart Lung 37(5):356-365, 2008.
|
White RE. Health Information Technology will Shift the Medical Care Paradigm. J Gen Intern Med. 23(4):495-499, 2008.
|
Somkin CP, Altschuler A, Ackerson L, Tolsma D, Rolnick SJ, Yood R, Weaver WD, Von Worley A, Hornbrook M, Magid DJ, Go AS. Cardiology Clinical Trial Participation in Community-Based Healthcare Systems: Obstacles and Opportunities. Contemporary Clinical Trials 29(5):646-653, 2008.
|
Walsh KE, Dodd KS, Seetharaman K, Roblin DW, Herrinton LJ, Von Worley A, Usmani GN, Baer D, Gurwitz J. Medication Errors among Adults and Children with Cancer in the Outpatient Setting. Journal of Oncology 12/29/2008; Published online: 10.1200/JCO.2008.18.6072.
|
Mapel DW, Robinson SB, Lydick E. A Comparison of Health-Care Costs in Patients with Chronic Obstructive Pulmonary Disease Using Lightweight Portable Oxygen Systems versus Traditional Compressed-Oxygen Systems. Respir Care 53(9):1169-1175, 2008.
|
Earnshaw SR, Wilson MR, Dalal AA, Chambers MG, Jhingran P, Stanford R, Mapel DW. Cost-Effectiveness of Fluticasone Propionate/Salmeterol (500/50 microg) in the Treatment of COPD. Respir Med 103(1):12-21, 2009; Epub 2008 Nov 17.
|